Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Christian Dokomajilar"'
Autor:
Lisa M. Bebell, Grant Dorsey, Wilson Kambale, Philip J. Rosenthal, Christian Dokomajilar, Heidi Hopkins
Publikováno v:
The Journal of Infectious Diseases. 197:510-518
In Africa fever is often treated presumptively as malaria resulting in misdiagnosis and the overuse of antimalarial drugs. Rapid diagnostic tests (RDTs) for malaria may allow improved fever management. We compared RDTs based on histidine-rich protein
Autor:
Issaka Zongo, Christian Dokomajilar, Noel Rouamba, Jean-Bosco Ouédraogo, Halidou Tinto, Grant Dorsey, Philip J. Rosenthal, Robert T. Guiguemdé
Publikováno v:
The Lancet. 369:491-498
Summary Background Artemisinin-based combination regimens are widely advocated for malarial treatment, but other effective regimens might be cheaper and more readily available. Our aim was to compare the risk of recurrent parasitaemia in patients giv
Autor:
Philip J. Rosenthal, Elaine J. Carlson, Jonathan M. Woo, Grant Dorsey, Bryan Greenhouse, Christian Dokomajilar, Alissa Myrick
Publikováno v:
The American Journal of Tropical Medicine and Hygiene. 75:836-842
Genotyping methods for Plasmodium falciparum drug efficacy trials have not been standardized and may fail to accurately distinguish recrudescence from new infection, especially in high transmission areas where polyclonal infections are common. We dev
Autor:
Sarah G. Staedke, Philip J. Rosenthal, Moses R. Kamya, Christian Dokomajilar, Moses Kiggundu, Grant Dorsey
Publikováno v:
The American Journal of Tropical Medicine and Hygiene. 71:758-763
Antimalarial resistance to sulfadoxine-pyrimethamine (SP) is mediated by mutations in the dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) genes. However, the relative importance of different mutations is incompletely understood and
Publikováno v:
Antimicrobial Agents and Chemotherapy. 51:3023-3025
Key parasite polymorphisms were assessed in subjects treated for malaria with artesunate-amodiaquine in Tororo, Uganda. For pfcrt , all of the isolates tested had the CVIET haplotype. For pfmdr1 , 86Y and 1246Y were common at baseline and their preva
Publikováno v:
Antimicrobial Agents and Chemotherapy. 50:1893-1895
Polymorphisms in the Plasmodium falciparum pfmdr1 gene were assayed in pretreatment samples and in samples from patients reinfected following therapy with artemether-lumefantrine. The pfmdr1 alleles 86N, 184F, and 1246D significantly increased in pre
Autor:
Anyirékun Fabrice Somé, Jean-Bosco Ouédraogo, Bryan Greenhouse, Noel Rouamba, Issaka Zongo, Yves Y. Séré, Christian Dokomajilar, Philip J. Rosenthal
Publikováno v:
Antimicrobial agents and chemotherapy. 54(5)
Artemether-lumefantrine (AL), dihydroartemisinin-piperaquine (DP), and amodiaquine-sulfadoxine-pyrimethamine (AQ-SP) offer excellent antimalarial efficacy but may select for parasite polymorphisms that decrease drug sensitivity. We evaluated the sele
Publikováno v:
Antimicrobial agents and chemotherapy. 51(9)
Antimalarial clinical trials use genotyping techniques to distinguish new infection from recrudescence. In areas of high transmission, the accuracy of genotyping may be compromised due to the high number of infecting parasite strains. We compared the
Autor:
Philip J. Rosenthal, Issaka Zongo, Christian Dokomajilar, Grant Dorsey, Jean-Bosco Ouédraogo, Yves Y. Séré, Noel Rouamba
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 45(11)
BACKGROUND: Combination antimalarial therapy is advocated to improve treatment efficacy and limit selection of drug-resistant parasites. We compared the efficacies of 3 combination regimens in Bobo-Dioulasso, Burkina Faso: amodiaquine plus sulfadoxin
Autor:
Bryan, Greenhouse, Alissa, Myrick, Christian, Dokomajilar, Jonathan M, Woo, Elaine J, Carlson, Philip J, Rosenthal, Grant, Dorsey
Publikováno v:
The American journal of tropical medicine and hygiene. 75(5)
Genotyping methods for Plasmodium falciparum drug efficacy trials have not been standardized and may fail to accurately distinguish recrudescence from new infection, especially in high transmission areas where polyclonal infections are common. We dev